Latest topics | Infection Update

LATEST TOPICS

Cigarette smoking enhances MRSA

11 October, 2019

New evidence from scientists at the University of Bath suggests that the ability of the superbug, methicillin-resistant Staphylococcus aureus (MRSA), to resist antibiotics is enhanced by the presence of cigarette...

New evidence from scientists at the University of Bath suggests that the ability of the superbug, methicillin-resistant Staphylococcus aureus (MRSA), to resist antibiotics is enhanced by the presence of cigarette...

Beneficial short-course antibiotic for pneumonia – A call for awareness

08 September, 2019

More than two-thirds of patients hospitalised with pneumonia were prescribed with excess duration of antibiotic therapy, reports a retrospective cohort study conducted in 43 hospitals in Michigan, United States.1 Antibiotics...

More than two-thirds of patients hospitalised with pneumonia were prescribed with excess duration of antibiotic therapy, reports a retrospective cohort study conducted in 43 hospitals in Michigan, United States.1 Antibiotics...

Respiratory syncytial virus (RSV) – not bacteria – a leading cause of childhood pneumonia

02 August, 2019

Researchers of the Pneumonia Etiology Research for Child Health (PERCH) study reported that viruses are the leading cause of severe pneumonia in children younger than five years without human immunodeficiency...

Researchers of the Pneumonia Etiology Research for Child Health (PERCH) study reported that viruses are the leading cause of severe pneumonia in children younger than five years without human immunodeficiency...

Previously unknown bacterial communities responsible for recurrent urinary tract infections in postmenopausal women

Researchers at The University of Texas (UT) at Dallas and UT Southwestern Medical Center have identified several species of bacteria that form bacterial communities responsible for recurrent urinary tract infections...

Researchers at The University of Texas (UT) at Dallas and UT Southwestern Medical Center have identified several species of bacteria that form bacterial communities responsible for recurrent urinary tract infections...

Superbugs found on patients’ hands at the start of hospitalisation

The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) have been advocating for hand hygiene as an important tool in infection control within healthcare facilities.1,2 Campaigns...

The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) have been advocating for hand hygiene as an important tool in infection control within healthcare facilities.1,2 Campaigns...

Levofloxacin: High-dose, short-course for bacterial infection

Associate Professor Panpit Suwangool Bangkok Hospital, Thailand Levofloxacin is a well-established antibacterial for respiratory and urinary tract infections.1 Levofloxacin is active against some penicillin- and macrolide- resistant pathogens including Streptococcus...

Associate Professor Panpit Suwangool Bangkok Hospital, Thailand Levofloxacin is a well-established antibacterial for respiratory and urinary tract infections.1 Levofloxacin is active against some penicillin- and macrolide- resistant pathogens including Streptococcus...

Oral sitafloxacin vs intravenous ceftriaxone for the treatment of acute pyelonephritis and complicated urinary tract infection

An open-label randomised, controlled, noninferiority clinical trial has shown that oral sitafloxacin is noninferior to intravenous (IV) ceftriaxone followed by oral cefdinir for the treatment of acute pyelonephritis and complicated...

An open-label randomised, controlled, noninferiority clinical trial has shown that oral sitafloxacin is noninferior to intravenous (IV) ceftriaxone followed by oral cefdinir for the treatment of acute pyelonephritis and complicated...

Levofloxacin remains as one of the core agents in the treatment of tuberculosis

According to the current World Health Organization (WHO) guidelines (2016 update), fluoroquinolones including moxifloxacin, gatifloxacin, and levofloxacin are important second-line anti-tuberculosis (anti-TB) agents.1 A review of existing literature conducted by...

According to the current World Health Organization (WHO) guidelines (2016 update), fluoroquinolones including moxifloxacin, gatifloxacin, and levofloxacin are important second-line anti-tuberculosis (anti-TB) agents.1 A review of existing literature conducted by...

First malaria saliva test identifies malaria parasites

Researchers have developed a non-invasive, easy-to-use saliva test to screen for malaria parasites before patients present any clinical symptoms. An estimated 219 million malaria cases were reported in 2017 –...

Researchers have developed a non-invasive, easy-to-use saliva test to screen for malaria parasites before patients present any clinical symptoms. An estimated 219 million malaria cases were reported in 2017 –...

Oral levofloxacin and intravenous vancomycin for bacteraemia due to Microbacterium paraoxydans

A patient with bacteraemia associated with a long-term central venous catheter (CVC) due to Microbacterium paraoxydans responded well to replacement of CVC, and treatment with oral levofloxacin and intravenous vancomycin....

A patient with bacteraemia associated with a long-term central venous catheter (CVC) due to Microbacterium paraoxydans responded well to replacement of CVC, and treatment with oral levofloxacin and intravenous vancomycin....

POPULAR ARTICLES